{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:22Z","timestamp":1786118722400,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"Zambon U.S. Ltd."}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>A better understanding of chronic lung allograft dysfunction (CLAD) natural history could be useful in targeting interventions to those most likely to progress. We hypothesized that pre-CLAD lung function trajectory would predict post-CLAD lung function and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We identified first lung transplant recipients between January 1, 2000, and January 1, 2020, diagnosed with probable or definite CLAD. We examined the trajectory of forced expiratory volume in 1\u2009s (FEV1) in the 3 mo before CLAD onset and divided patients into 3 groups based on slow, intermediate, or rapid decline in FEV1. We compared clinical characteristics, post-CLAD pulmonary function changes, and survival between these groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>There were 293 subjects with CLAD meeting eligibility criteria, including 162 bilateral orthotopic lung transplant (BOLT) and 131 single orthotopic lung transplant (SOLT) recipients. In BOLT recipients, intermediate and rapid progressors had significantly lower FEV1 and forced vital capacity at 3 and 6 mo post-CLAD as compared with slow progressors. Among SOLT, rapid progressors also had significantly lower FEV1 and forced vital capacity at 3 and 6 mo post-CLAD. Mortality was also increased in intermediate and rapid progressors compared with slow progressors. In an adjusted Cox proportional hazards regression model, rapid pre-CLAD progression and higher CLAD stage were associated with increased hazard of CLAD progression in entire cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Rates of FEV1 decline in the 3 mo before CLAD onset predict CLAD progression and mortality after CLAD onset in BOLT and SOLT recipients. The ability to predict CLAD progression at CLAD onset could help enrich future interventional trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005703","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:00:53Z","timestamp":1776708053000},"page":"e1317-e1326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Natural History of Chronic Lung Allograft Dysfunction in Single and Bilateral Orthotopic Lung Transplant Recipients"],"prefix":"10.1097","volume":"110","author":[{"given":"Shahrzad","family":"M. Lari","sequence":"first","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Feilding School of Public Health, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Feilding School of Public Health, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Sayah","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariss","family":"Der Hovanessian","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Shino","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olawale","family":"Amubieya","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ardehali","sequence":"additional","affiliation":[{"name":"Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh S.","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Belperio","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sam","family":"Weigt","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"R1-20260521","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report\u20142021; focus on recipient characteristics.","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOT.0000000000000753","article-title":"Survival in adult lung transplantation: where are we in 2020?","volume":"25","author":"Bos","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"R3-20260521","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the pulmonary council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: a systematic review of mechanisms.","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"e0260881","DOI":"10.1371\/journal.pone.0260881","article-title":"Disease progression in patients with the restrictive and mixed phenotype of chronic lung allograft dysfunction\u2014a retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.","volume":"16","author":"Gottlieb","year":"2021","journal-title":"PLoS One"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1164\/rccm.200609-1344OC","article-title":"Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.","volume":"175","author":"Lama","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healun.2018.10.006","article-title":"Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.","volume":"38","author":"Todd","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1513\/AnnalsATS.201510-719OC","article-title":"Validation and refinement of chronic lung allograft dysfunction phenotypes in bilateral and single lung recipients.","volume":"13","author":"DerHovanessian","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/14017431.2020.1726444","article-title":"Incidence and impact of chronic lung allograft dysfunction after lung transplantation\u2014single-center 14-year experience.","volume":"54","author":"Nykanen","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.healun.2013.01.1054","article-title":"Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).","volume":"32","author":"Sato","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1164\/rccm.201002-0211OC","article-title":"Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.","volume":"182","author":"Finlen Copeland","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/arm91050033","article-title":"Chronic lung allograft dysfunction is associated with significant disability after lung transplantation\u2014a burden of disease analysis in 1025 cases.","volume":"91","author":"Diel","year":"2023","journal-title":"Adv Respir Med"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/ajt.17108","article-title":"Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.","volume":"22","author":"Shino","year":"2022","journal-title":"Am J Transplant"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI93537","article-title":"Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.","volume":"127","author":"Weigt","year":"2017","journal-title":"J Clin Invest"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/ajt.13475","article-title":"The role of TGF-beta in the association between primary graft dysfunction and bronchiolitis obliterans syndrome.","volume":"16","author":"DerHovanessian","year":"2016","journal-title":"Am J Transplant"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/ajt.12131","article-title":"Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.","volume":"13","author":"Weigt","year":"2013","journal-title":"Am J Transplant"},{"key":"R17-20260521","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.16827","article-title":"The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.","volume":"22","author":"Shino","year":"2022","journal-title":"Am J Transplant"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1164\/rccm.201306-1155OC","article-title":"Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.","volume":"189","author":"Todd","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12890-024-03009-6","article-title":"Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis.","volume":"24","author":"Watanabe","year":"2024","journal-title":"BMC Pulm Med"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.scitotenv.2016.10.232","article-title":"Removal of phenol, bisphenol A, and 4-tert-butylphenol from synthetic landfill leachate by vertical flow constructed wetlands.","volume":"578","author":"A","year":"2017","journal-title":"Sci Total Environ"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/ajt.13281","article-title":"Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study.","volume":"15","author":"Verleden","year":"2015","journal-title":"Am J Transplant"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.healun.2022.01.015","article-title":"Phenotyping CLAD after single lung transplant: limits and prognostic assessment of the 2019 ISHLT classification system.","volume":"41","author":"Berra","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2020.08.008","article-title":"Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.","volume":"39","author":"Leuschner","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1164\/rccm.202403-0568OC","article-title":"Prognosis and risks for probable chronic lung allograft dysfunction: a prospective multicenter study.","volume":"211","author":"Todd","year":"2025","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:48:39Z","timestamp":1786034919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005703","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]}}}